A photo of Adam Lane.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Assistant Professor, UC Department of Pediatrics



Biography & Affiliation


Dr. Lane joined Cincinnati Children's in July 2013. He has published novel statistical methods in the areas of adaptive and optimal experimental designs with applications to phase I and phase II clinical trials. As a graduate student he received funding from the NIH to spend the fall semester of 2011 at the University of Cambridge in the Isaac Newton Institute for Mathematical Sciences. He has also received NSF travel awards to present his research at national and international conferences.

Research Interests

Clinical trials; survival analysis; structural equation modeling

Academic Affiliation

Assistant Professor, UC Department of Pediatrics


Experimental Hematology and Cancer Biology, Cancer and Blood Diseases, Biostatistics


PhD: University of Missouri, Columbia, MO, 2013.


Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al. Blood. 2020; 26:S138-S138.

CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells. Khandelwal, P; Chaturvedi, V; Owsley, E; Lane, A; Heyenbruch, D; Lutzko, CM; Leemhuis, T; Grimley, MS; Nelson, AS; Davies, SM; et al. Biology of Blood and Marrow Transplantation. 2020; 26:1-6.

Cell type-specific mechanisms coupling protease-activated receptor-1 to infectious colitis pathogenesis. Boucher, AA; Rosenfeldt, L; Mureb, D; Shafer, J; Sharma, BK; Lane, A; Crowther, RR; McKell, MC; Whitt, J; Alenghat, T; et al. Journal of Thrombosis and Haemostasis. 2020; 18:91-103.

Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al. Pediatric Blood and Cancer. 2019; 66.

Graphical data mining of cancer mechanisms with SEMA. Solmaz, M; Lane, A; Gonen, B; Akmamedova, O; Gunes, MH; Komurov, K. Bioinformatics. 2019; 35:4413-4418.

Magnetic Resonance Fingerprinting to Characterize Childhood and Young Adult Brain Tumors. de Blank, P; Badve, C; Gold, DR; Stearns, D; Sunshine, J; Dastmalchian, S; Tomei, K; Sloan, AE; Barnholtz-Sloan, JS; Lane, A; et al. Pediatric Neurosurgery. 2019; 54:310-318.

A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation. Benoit, SW; Dixon, BP; Goldstein, SL; Bennett, MR; Lane, A; Lounder, DT; Rotz, SJ; Gloude, NJ; Lake, KE; Litts, B; et al. Bone Marrow Transplantation. 2019; 54:1453-1461.

Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia. McGann, PT; Niss, O; Dong, M; Marahatta, A; Howard, TA; Mizuno, T; Lane, A; Kalfa, TA; Malik, P; Quinn, CT; et al. American Journal of Hematology. 2019; 94:871-879.

Comparing a Neutropenic Diet to a Food Safety-Based Diet in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation. Taggart, C; Neumann, N; Alonso, PB; Lane, A; Pate, A; Stegman, A; Stendahl, A; Davies, SM; Dandoy, CE; Grimley, M. Biology of Blood and Marrow Transplantation. 2019; 25:1382-1386.

Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy. Schuh, MP; Bennett, MR; Lane, A; Jodele, S; Laskin, BL; Devarajan, P. Pediatric Nephrology. 2019; 34:865-871.